MoneyWorks4Me

Thermax, InterGlobe Aviation and Indian Bank to see some action today

16 Sep 2024 Evaluate

Thermax’s wholly owned subsidiary -- Thermax Babcock & Wilcox Energy Solutions (TBWES) has received a repeat order worth Rs 516 crore for setting up another 300 MW energy project from an industrial conglomerate in Botswana, Southern Africa. This order is part of the second phase of a 600 MW project being developed by the major, positioning Thermax as the sole partner for the entire project.

InterGlobe Aviation (IndiGo) has reported the Passenger Load Factor (PLF) of 82.3% during the month of August 2024. The company had reported PLF of 84.6% during the month of July 2024. The PLF is a key indicator of the company’s performance, as it measures the average percentage of seats filled on airline’s aircraft fleet.  

Indian Bank has raised Rs 5000 crore through the allotment of 7.24%, Senior, Rated, Listed, Unsecured, Redeemable, Long Term Fully Paid-up Non-Convertible Bonds in the nature of Debentures Series I. Date of Allotment is September 13, 2024. 

Oriental Rail Infrastructure has secured order worth Rs 1.43 crore from Integral Coach Factory (ICF), Chennai, Indian Railways for supply and installation of 16 sets of ‘Seats and Berths’ with hardwares for LWSCN PP coach. The said order is expected to be completed by October 13, 2024. 

Styrenix Performance Materials has incorporated Wholly Owned Subsidiary (WOS) namely ‘Styrenix Performance Materials FZE’ at free trade zone in United Arab Emirates (UAE) on September 10, 2024. The WOS is incorporated with object of General Trading. 

SpiceJet has reported the Passenger Load Factor (PLF) of 81% during the month of August 2024. The company had reported PLF of 90.3% during the month of July 2024. The PLF is a key indicator of the company’s performance, as it measures the average percentage of seats filled on airline’s aircraft fleet. 

Zydus Lifesciences’ wholly owned subsidiary -- Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals (Viwit), an innovation driven biopharmaceutical and healthcare company, for gadobutrol injection (generic version of GADAVIST) and gadoterate meglumine injection (generic version of DOTAREM) for the US market.


About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: